Our Team

World-Class
Leadership

Led by a highly experienced team with in-depth expertise in AI and Biomedical Engineering.

Leadership

Dr. Lurong Pan

Lurong Pan, PhD

Founder & CEO

MFE from UC Berkeley Haas School of Business, MS Artificial Intelligence (Georgia Tech), PhD Computational Biology (UAB) with structural biology postdoc. 16+ years in computational drug design across small molecule, protein, and RNA modalities. Senior Investigator at the Bill & Melinda Gates Foundation. Former Director & Senior Scientist at UAB Medicine. Founder & CEO of Ainnocence.

Kevin Jin

Kevin Jin, MS

Chief Biomedical AI Scientist

10 years of research and product development. Deep expertise in medical ML/AI drug discovery. MS in Biomedical Engineering from Columbia University.

Roger Wang

Roger Wang, MS

Chief AI Engineer

4 years AI/ML platform engineering industry experience. MS in Data Science from University of Southern California.

Dr. Kyle Brewer

Kyle Brewer, PhD

Chief Therapeutic Officer

Associate Director, Stanford University. Co-founder ETTA Biotech. Former OpenAI. PhD Molecular Biophysics, UT Southwestern.

Core Team

Alejandra Martín

Alejandra Martín

Senior Biologist

UC Davis (Biotechnology), pursuing dual masters in Molecular Biology and Bioinformatics. Former SRA/Scientist at Retro Biosciences (stem cell reprogramming, longevity research) and Sangamo Therapeutics (allogeneic cell therapies, Zinc Finger gene editing). Passionate about the convergence of biology, AI, and technology.

Len Brioso

Len Brioso

Client Success Manager

6 years commercial experience in account management, executive support, and marketing.

Advisors

Dr. Sheng Ding

Sheng Ding, PhD

Scientific Advisor

Professor UCSF. Co-founder: Fate Therapeutics, Tenaya Therapeutics. Pioneer in chemical approaches to stem cell biology. 300+ publications.

Dr. Murat Tanik

Murat Tanik, PhD

Scientific Advisor

Wallace R. Bunn Endowed Chair, UAB. Former Director, UT Austin. Co-director Integrated Systems Center. Co-founder, Society for Design and Process Science. PhD Computer Science, Texas A&M.

Dr. Liang Zhu

Liang Zhu, PhD

Industry Advisor

20+ years preclinical drug discovery across oncology, immunology, neuroscience, and metabolic disease. Former Associate Principal Scientist at Merck & Co. (Schering-Plough) — advanced two compounds to clinical trials including the first-in-class ERK inhibitor MK-8353. Deep expertise in ADC/bsADC and degrader-antibody conjugate (DAC) design. PhD Organic Chemistry, UC Irvine.

Join Our Mission

We're always looking for exceptional talent to help us cure the incurables. Join our team of world-class scientists and engineers.

View Openings